.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Covington
Moodys
Queensland Health
Daiichi Sankyo
Federal Trade Commission
Chubb
Merck
QuintilesIMS
Medtronic

Generated: December 16, 2017

DrugPatentWatch Database Preview

INTAL Drug Profile

« Back to Dashboard

Which patents cover Intal, and what generic alternatives are available?

Intal is a drug marketed by King Pharms Llc and Sanofi Aventis Us and is included in three NDAs.

The generic ingredient in INTAL is cromolyn sodium. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
Drug patent expirations by year for INTAL

Medical Subject Heading (MeSH) Categories for INTAL

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms LlcINTALcromolyn sodiumAEROSOL, METERED;INHALATION018887-001Dec 5, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis UsINTALcromolyn sodiumCAPSULE;INHALATION016990-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
King Pharms LlcINTALcromolyn sodiumSOLUTION;INHALATION018596-001May 28, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: INTAL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis UsINTALcromolyn sodiumCAPSULE;INHALATION016990-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
King Pharms LlcINTALcromolyn sodiumSOLUTION;INHALATION018596-001May 28, 1982► Subscribe► Subscribe
King Pharms LlcINTALcromolyn sodiumAEROSOL, METERED;INHALATION018887-001Dec 5, 1985► Subscribe► Subscribe
Sanofi Aventis UsINTALcromolyn sodiumCAPSULE;INHALATION016990-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
King Pharms LlcINTALcromolyn sodiumSOLUTION;INHALATION018596-001May 28, 1982► Subscribe► Subscribe
Sanofi Aventis UsINTALcromolyn sodiumCAPSULE;INHALATION016990-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis UsINTALcromolyn sodiumCAPSULE;INHALATION016990-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
King Pharms LlcINTALcromolyn sodiumAEROSOL, METERED;INHALATION018887-001Dec 5, 1985► Subscribe► Subscribe
Sanofi Aventis UsINTALcromolyn sodiumCAPSULE;INHALATION016990-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis UsINTALcromolyn sodiumCAPSULE;INHALATION016990-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Fish and Richardson
QuintilesIMS
Johnson and Johnson
Colorcon
US Department of Justice
Merck
McKinsey
Harvard Business School
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot